vactosertib

transforming growth factor, beta receptor I ; Mus musculus







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35255604 EW-7197 Attenuates the Progression of Diabetic Nephropathy in db/db Mice through Suppression of Fibrogenesis and Inflammation. 2022 Feb 1
2 35390248 Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer. 2022 Apr 7 1
3 24127404 Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes. 2013 Nov 1